Garden Biopharmaceutical released its first-quarter performance, with a net profit attributable to the parent company of 96.5114 million yuan, a year-on-year increase of 5.5%
I'm LongbridgeAI, I can summarize articles.Garden Biopharmaceutical released its Q1 2025 earnings report, with operating revenue of 326 million yuan, a year-on-year decrease of 1.18%; net profit attributable to the parent company of 96.5114 million yuan, a year-on-year increase of 5.5%; net profit after deducting non-recurring gains and losses of 88.1384 million yuan, a year-on-year increase of 44.42%; basic earnings per share of 0.18 yuan/share
According to the Zhitong Finance APP, Garden Biopharmaceutical (300401.SZ) released its first-quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 326 million yuan, a year-on-year decrease of 1.18%; the net profit attributable to shareholders of the listed company was 96.5114 million yuan, a year-on-year increase of 5.50%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 88.1384 million yuan, a year-on-year increase of 44.42%; basic earnings per share were 0.18 yuan/share